bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Up 100.9% in April

bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 260,000 shares, a growth of 100.9% from the March 31st total of 129,400 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 2,600.0 days.

bioMérieux Price Performance

bioMérieux stock remained flat at $130.17 during trading hours on Friday. The firm has a fifty day moving average of $125.85 and a 200-day moving average of $115.73. The company has a quick ratio of 1.20, a current ratio of 2.21 and a debt-to-equity ratio of 0.10. bioMérieux has a 1 year low of $93.50 and a 1 year high of $134.38.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.